Relay Therapeutics Inc (NASDAQ: RLAY) open the trading on Wednesday, with a bit cautious approach as it glided -2.92% to $4.66, before settling in for the price of $4.80 at the close. Taking a more long-term approach, RLAY posted a 52-week range of $4.70-$12.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 319.82%. Meanwhile, its Annual Earning per share during the time was -38.74%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.22%. This publicly-traded company’s shares outstanding now amounts to $127.46 million, simultaneously with a float of $121.92 million. The organization now has a market capitalization sitting at $780.01 million. At the time of writing, stock’s 50-day Moving Average stood at $6.48, while the 200-day Moving Average is $7.35.
Relay Therapeutics Inc (RLAY) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Relay Therapeutics Inc’s current insider ownership accounts for 27.16%, in contrast to 73.09% institutional ownership. According to the most recent insider trade that took place on Oct 28 ’24, this organization’s insider sold 1,621 shares at the rate of 6.06, making the entire transaction reach 9,823 in total value, affecting insider ownership by 390,063. Preceding that transaction, on Oct 28 ’24, Company’s Chief Financial Officer sold 6,802 for 6.06, making the whole transaction’s value amount to 41,220. This particular insider is now the holder of 306,391 in total.
Relay Therapeutics Inc (RLAY) Earnings and Revenue Records
Relay Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 8.22% and is forecasted to reach -2.64 in the upcoming year.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Let’s observe the current performance indicators for Relay Therapeutics Inc (RLAY). It’s Quick Ratio in the last reported quarter now stands at 18.42. The Stock has managed to achieve an average true range (ATR) of 0.36. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 77.92.
In the same vein, RLAY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.61, a figure that is expected to reach -0.61 in the next quarter, and analysts are predicting that it will be -2.64 at the market close of one year from today.
Technical Analysis of Relay Therapeutics Inc (RLAY)
[Relay Therapeutics Inc, RLAY] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 4.90% While, its Average True Range was 0.34.
Raw Stochastic average of Relay Therapeutics Inc (RLAY) in the period of the previous 100 days is set at 2.57%, which indicates a major fall in contrast to 8.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.09% that was lower than 94.11% volatility it exhibited in the past 100-days period.
